發送短信 : Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial

  _____     _____   __    __   _    _    __   _   
 / ____||  |  ___|| \ \\ / // | || | || | || | || 
/ //---`'  | ||__    \ \/ //  | || | || | '--' || 
\ \\___    | ||__     \  //   | \\_/ || | .--. || 
 \_____||  |_____||    \//     \____//  |_|| |_|| 
  `----`   `-----`      `       `---`   `-`  `-`